Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Therapeutic Products (ATP), also known as ATP Bio, is a clinical-stage biotechnology company headquartered in Suzhou, China, with additional research and development operations in San Diego, California. The company focuses on the development of next-generation mRNA-based therapeutics and innovative cell therapies, leveraging its proprietary mRNA synthesis and lipid nanoparticle (LNP) delivery platforms. ATP's pipeline includes mRNA vaccines for infectious diseases such as COVID-19 and Hepatitis B, as well as cell therapy programs targeting oncology indications like liver cancer. By integrating advanced genetic engineering with specialized delivery technologies, the company aims to address significant unmet medical needs in global health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Therapeutic Products.